Repligen (RGEN) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $748.7 million.
- Repligen's Cash & Equivalents fell 449.22% to $748.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $748.7 million, marking a year-over-year decrease of 449.22%. This contributed to the annual value of $757.6 million for FY2024, which is 84.1% up from last year.
- Per Repligen's latest filing, its Cash & Equivalents stood at $748.7 million for Q3 2025, which was down 449.22% from $708.9 million recorded in Q2 2025.
- Repligen's 5-year Cash & Equivalents high stood at $809.1 million for Q2 2024, and its period low was $516.6 million during Q1 2023.
- Moreover, its 5-year median value for Cash & Equivalents was $697.2 million (2025), whereas its average is $670.4 million.
- In the last 5 years, Repligen's Cash & Equivalents crashed by 1876.75% in 2022 and then surged by 5110.4% in 2024.
- Repligen's Cash & Equivalents (Quarter) stood at $603.8 million in 2021, then fell by 13.31% to $523.5 million in 2022, then skyrocketed by 43.53% to $751.3 million in 2023, then rose by 0.84% to $757.6 million in 2024, then decreased by 1.17% to $748.7 million in 2025.
- Its last three reported values are $748.7 million in Q3 2025, $708.9 million for Q2 2025, and $697.2 million during Q1 2025.